Abstract
Microbes are widely utilized as workhorses for production of numerous valuable metabolites with utility in different sectors including food, energy, environment, agriculture, health, and disease management. Microbes are capable of synthesizing spectrum of structurally divergent compounds, which are even difficult to be prepared by chemical synthesis. Microbes synthesize many metabolites of interest naturally as an intermediate/product of their metabolic pathways, or another approach is redesigning/creating biosynthetic pathways in microbes for production of non-native target metabolite from simple and cheap substrates not only at laboratory scale but also at the industrial scale. Advancements in genetic engineering, genome sequencing, transcriptomics, proteomics, and computational approaches have revolutionized the identification of novel bioactive molecules of microbial origin and redesigning of microbial biosynthetic pathways. The present book chapter focuses primarily on microbial products including enzymes, proteins, chemicals, and secondary metabolites as well as their production strategies, their application in various fields, and development of engineered microbes as production factories.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Abou-Zeid A, Fouad M, Yassein M (1978) Microbiological production of acetone-butanol by Clostridium acetobutylicum. Zentralbl Bakteriol Parasitenkunde Infektionskr Hyg Zweite Naturwiss Abt Mikrobiol Landwirtsch Technol Umweltschutzes 133:125–134
Adrio JL, Demain AL (2014) Microbial enzymes: tools for biotechnological processes. Biomol Ther 4:117–139
Ageitos J, Sánchez-Pérez A, Calo-Mata P, Villa T (2017) Antimicrobial peptides (AMPs): ancient compounds that represent novel weapons in the fight against bacteria. Biochem Pharmacol 133:117–138
Agnandji ST et al (2017) Safety and immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine in adults and children in Lambaréné, Gabon: a phase I randomised trial. PLoS Med 14:e1002402
Aharonowitz Y (1980) Nitrogen metabolite regulation of antibiotic biosynthesis. Ann Rev Microbiol 34:209–233
Ahmad M, Hirz M, Pichler H, Schwab H (2014) Protein expression in Pichia pastoris: recent achievements and perspectives for heterologous protein production. Appl Microbiol Biotechnol 98:5301–5317
Akash MSH, Rehman K, Tariq M, Chen S (2015) Development of therapeutic proteins: advances and challenges. Turk J Biol 39:343–358
Anbu P, Gopinath SC, Chaulagain BP, Tang T-H, Citartan M (2015) Microbial enzymes and their applications in industries and medicine. Biomed Res Int 2015:816419
Andrade MR, Costa JA (2007) Mixotrophic cultivation of microalga Spirulina platensis using molasses as organic substrate. Aquaculture 264:130–134
Aravindan R, Anbumathi P, Viruthagiri T (2007) Lipase applications in food industry. Indian J Biotechnol 6:141–158
Archer DB (2000) Filamentous fungi as microbial cell factories for food use. Curr Opin Biotechnol 11:478–483
Aronson SM (2012) A proliferation of pro-words Rhode island. Med J 95:371
Aruna K, Shah J, Birmole R (2014) Production and partial characterization of alkaline protease from Bacillus tequilensis strains CSGAB0139 isolated from spoilt cottage cheese. Int J Appl Biol Pharm 5:201–221
Bachran C, Leppla SH (2016) Tumor targeting and drug delivery by anthrax toxin. Toxins 8:197
Baldauf KJ, Royal JM, Hamorsky KT, Matoba N (2015) Cholera toxin B: one subunit with many pharmaceutical applications. Toxins 7:974–996
Banerjee A, Chisti Y, Banerjee U (2004) Streptokinase—a clinically useful thrombolytic agent. Biotechnol Adv 22:287–307
Bate C, Salmona M, Diomede L, Williams A (2004) Squalestatin cures prion-infected neurons and protects against prion neurotoxicity. J Biol Chem 279:14983–14990
Bechinger B (1997) Structure and functions of channel-forming peptides: magainins, cecropins, melittin and alamethicin. J Membr Biol 156:197–211
Beekwilder J, Wolswinkel R, Jonker H, Hall R, de Vos CR, Bovy A (2006) Production of resveratrol in recombinant microorganisms. Appl Environ Microbiol 72:5670–5672
Bennett WM, Singer I, Golper T, Feig P, Coggins CJ (1977) Guidelines for drug therapy in renal failure. Ann Intern Med 86:754–783
Bentley R (1999) Secondary metabolite biosynthesis: the first century. Crit Rev Biotechnol 19:1–40
Bentley SD et al (2002) Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2). Nature 417:141
Bérdy J (2005) Bioactive microbial metabolites. J Antibiot 58:1
Berg JM, Tymoczko JL, Stryer L (2002) Protein structure and function. In: Biochemistry, 5th edn. W. H. Freeman & Co Ltd, New York
Bibb MJ (2005) Regulation of secondary metabolism in streptomycetes. Curr Opin Microbiol 8:208–215
Biebl H, Menzel K, Zeng AP, Deckwer WD (1999) Microbial production of 1, 3-propanediol. Appl Microbiol Biotechnol 52:289–297
Bill RM (2015) Recombinant protein subunit vaccine synthesis in microbes: a role for yeast? J Pharm Pharmacol 67:319–328
Blin K, Medema MH, Kazempour D, Fischbach MA, Breitling R, Takano E, Weber T (2013) antiSMASH 2.0—a versatile platform for genome mining of secondary metabolite producers. Nucleic Acids Res 41:W204–W212
Blomberg R et al (2013) Precision is essential for efficient catalysis in an evolved Kemp eliminase. Nature 503:418
Bornscheuer U, Huisman G, Kazlauskas R, Lutz S, Moore J, Robins K (2012) Engineering the third wave of biocatalysis. Nature 485:185
Bouras N, Holtz MD, Aboukhaddour R, Strelkov SE (2016) Influence of nitrogen sources on growth and mycotoxin production by isolates of Pyrenophora tritici-repentis from wheat. Crop J 4:119–128
Brezovsky J et al (2016) Engineering a de novo transport tunnel. ACS Catal 6:7597–7610
Brückner B (1992) Regulation of gibberellin formation by the fungus Gibberella fujikuroi. In: Secondary metabolites: their function and evolution. Wiley, Chichester, pp 129–143
Bu’Lock J (1961) Intermediary metabolism and antibiotic synthesis. In: Advances in applied microbiology, vol 3. Elsevier, pp 293–342
Burroughs JR, Anderson RL (2015) Cosmetic botulinum toxin applications: general considerations and dosing. In: Pearls and pitfalls in cosmetic oculoplastic surgery. Springer, New York, pp 393–394
Castanie-Cornet M-P, Penfound TA, Smith D, Elliott JF, Foster JW (1999) Control of acid resistance in Escherichia coli. J Bacteriol 181:3525–3535
Cech TR, Bass BL (1986) Biological catalysis by RNA. Annu Rev Biochem 55:599–629
Chae S, Hwang E, Shin H-S (2006) Single cell protein production of Euglena gracilis and carbon dioxide fixation in an innovative photo-bioreactor. Bioresour Technol 97:322–329
Chae TU, Choi SY, Kim JW, Ko Y-S, Lee SY (2017) Recent advances in systems metabolic engineering tools and strategies. Curr Opin Biotechnol 47:67–82
Challis GL (2008) Mining microbial genomes for new natural products and biosynthetic pathways. Microbiology 154:1555–1569
Chandola TR et al (2017) ROTAVAC® does not interfere with the immune response to childhood vaccines in Indian infants: a randomized placebo controlled trial. Heliyon 3:e00302
Chang C, Stewart RC (1998) The two-component system: regulation of diverse signaling pathways in prokaryotes and eukaryotes. Plant Physiol 117:723–731
Chemier JA, Fowler ZL, Koffas MA, Leonard E (2009) Trends in microbial synthesis of natural products and biofuels. Adv Enzymol Relat Area Mol Biol 76:151
Chen G-Q (2012) New challenges and opportunities for industrial biotechnology. Microb Cell Factories 11:111
Chen K, Arnold FH (1993) Tuning the activity of an enzyme for unusual environments: sequential random mutagenesis of subtilisin E for catalysis in dimethylformamide. Proc Natl Acad Sci 90:5618–5622
Chen MM, Snow CD, Vizcarra CL, Mayo SL, Arnold FH (2012) Comparison of random mutagenesis and semi-rational designed libraries for improved cytochrome P450 BM3-catalyzed hydroxylation of small alkanes. Protein Eng Des Sel 25:171–178
Cheng YR, Huang J, Qiang H, LIN WL, Demain AL (2001) Mutagenesis of the rapamycin producer Streptomyces hygroscopicus FC904. J Antibiot 54:967–972
Chiang Y-M, Lee K-H, Sanchez JF, Keller NP, Wang CC (2009) Unlocking fungal cryptic natural products. Nat Prod Commun 4:1505
Choudhary R, Jana A, Jha M (2004) Enzyme technology applications in leather processing. Indian J Chem Technol 11:659–671
Čurdová E, Jechová V, Zima J, Vaněk Z (1989) The effect of inorganic phosphate on the production of avermectin in Streptomyces avermitilis. J Basic Microbiol 29:341–346
Cutler HG (1995) Microbial natural products that affect plants, phytopathogens, and certain other microorganisms. Crit Rev Plant Sci 14:413–444
Daglia M (2012) Polyphenols as antimicrobial agents. Curr Opin Biotechnol 23:174–181
Damborsky J, Chaloupkova R, Pavlova M, Chovancova E, Brezovsky J (2010) Structure–function relationships and engineering of haloalkane dehalogenases. In: Handbook of hydrocarbon and lipid microbiology. Springer, Berlin/Heidelberg, pp 1081–1098
Davati N, Habibi Najafi MB (2013) Overproduction strategies for microbial secondary metabolites: a review. Int J Life Sci Pharma Res 3:23–27
Davies J (2011) How to discover new antibiotics: harvesting the parvome. Curr Opin Chem Biol 15:5–10
Del Tordello E, Rappuoli R, Delany I (2017) Reverse vaccinology: exploiting genomes for vaccine design. In: Human vaccines. Elsevier, pp 65–86
Demain AL (1998) Microbial natural products: alive and well in 1998. Nat Biotechnol 16:3
Demain AL, Adrio JL (2008) Contributions of microorganisms to industrial biology. Mol Biotechnol 38:41
Demain AL, Vaishnav P (2009) Production of recombinant proteins by microbes and higher organisms. Biotechnol Adv 27:297–306
Dhakal R, Bajpai VK, Baek K-H (2012) Production of GABA (γ-aminobutyric acid) by microorganisms: a review. Braz J Microbiol 43:1230–1241
Dien BS, Nichols NN, O’bryan PJ, Bothast RJ (2000) Development of new ethanologenic Escherichia coli strains for fermentation of lignocellulosic biomass. Appl Biochem Biotechnol 84:181–196
Dormitzer PR, Ulmer JB, Rappuoli R (2008) Structure-based antigen design: a strategy for next generation vaccines. Trends Biotechnol 26:659–667
Dormitzer PR, Grandi G, Rappuoli R (2012) Structural vaccinology starts to deliver. Nat Rev Microbiol 10:807
Doshi R, Shelke V (2001) Enzymes in textile industry-an environment-friendly approach. Indian J Fibre Text Res 26:202–205
Du J, Shao Z, Zhao H (2011) Engineering microbial factories for synthesis of value-added products. J Ind Microbiol Biotechnol 38:873–890
Dubos RJ (1939) Studies on a bactericidal agent extracted from a soil bacillus: I. Preparation of the agent. Its activity in vitro. J Exp Med 70:1
Dubos RJ, Cattaneo C (1939) Studies on a bactericidal agent extracted from a soil bacillus: III. Preparation and activity of a protein-free fraction. J Exp Med 70:249–256
Esnault C et al (2017) Strong antibiotic production is correlated with highly active oxidative metabolism in Streptomyces coelicolor M145. Sci Rep 7:200
Essig A et al (2014) Copsin, a novel peptide-based fungal antibiotic interfering with the peptidoglycan synthesis. J Biol Chem 289:34953–34964. M114. 599878
Fabbri A, Travaglione S, Falzano L, Fiorentini C (2008) Bacterial protein toxins: current and potential clinical use. Curr Med Chem 15:1116–1125
Fernandes P, Carvalho F (2017) Microbial enzymes for the food industry. In: Biotechnology of microbial enzymes. Elsevier, Amsterdam, pp 513–544
Ferrer-Miralles N, Domingo-Espín J, Corchero JL, Vázquez E, Villaverde A (2009) Microbial factories for recombinant pharmaceuticals. Microb Cell Factories 8:17
Fleming AG (1929) Responsibilities and opportunities of the private practitioner in preventive medicine. Can Med Assoc J 20:11
Foerster CW, Foerster HF (1973) Glutamic acid decarboxylase in spores of Bacillus megaterium and its possible involvement in spore germination. J Bacteriol 114:1090–1098
Foster JA, Wulc AE, Straka D, Cahill KV, Czyz C, Tan J (2018) Cosmetic uses of botulinum toxin. In: Manual of oculoplastic surgery. Springer, New York, pp 165–172
Franzoi M, van Heuvel Y, Thomann S, Schurch N, Kallio PT, Venier P, Essig A (2017) Structural insights into the mode of action of the peptide antibiotic copsin. Biochemistry 56:4992–5001
Garodia S, Naidu P, Nallanchakravarthula S (2017) QUORN: an anticipated novel protein source
Ghazi S, Sepahy AA, Azin M, Khaje K, Khavarinejad R (2014) UV mutagenesis for the overproduction of xylanase from Bacillus mojavensis PTCC 1723 and optimization of the production condition. Iran J Basic Med Sci 17:844
Giombini E, Orsini M, Carrabino D, Tramontano A (2010) An automatic method for identifying surface proteins in bacteria: SLEP. BMC Bioinformatics 11:39
Goeddel DV et al (1980) Human leukocyte interferon produced by E. coli is biologically active. Nature 287:411
Gonzalez JB, Fernandez F, Tomasini A (2003) Microbial secondary metabolites production and strain improvement. Indian J Biotechnol 2:322–333
Grandi G (2010) Bacterial surface proteins and vaccines. F1000 Biol Rep 2:36
Guazzaroni ME, Silva-Rocha R, Ward RJ (2015) Synthetic biology approaches to improve biocatalyst identification in metagenomic library screening. Microb Biotechnol 8:52–64
Gurung N, Ray S, Bose S, Rai V (2013) A broader view: microbial enzymes and their relevance in industries, medicine, and beyond. Biomed Res Int 2013:329121
Hara KY, Araki M, Okai N, Wakai S, Hasunuma T, Kondo A (2014) Development of bio-based fine chemical production through synthetic bioengineering. Microb Cell Factories 13:173
Hasan F, Shah AA, Javed S, Hameed A (2010) Enzymes used in detergents: lipases. Afr J Biotechnol 9:4836–4844
Haugh M, Gresset-Bourgeois V, Macabeo B, Woods A, Samson SI (2017) A trivalent, inactivated influenza vaccine (Vaxigrip®): summary of almost 50 years of experience and more than 1.8 billion doses distributed in over 120 countries. Expert Rev Vaccines 16:545–564
Headon D, Walsh G (1994) The industrial production of enzymes. Biotechnol Adv 12:635–646
Hermann B, Blok K, Patel MK (2007) Producing bio-based bulk chemicals using industrial biotechnology saves energy and combats climate change. Environ Sci Technol 41:7915–7921
Hodgson J (1994) Bulk amino–acid fermentation: technology and commodity trading. Nat Biotechnol 12:152
Hou J, Tyo KE, Liu Z, Petranovic D, Nielsen J (2012) Metabolic engineering of recombinant protein secretion by Saccharomyces cerevisiae. FEMS Yeast Res 12:491–510
Ivers LC et al (2015) Immunogenicity of the bivalent oral cholera vaccine Shanchol in Haitian adults with HIV infection. J Infect Dis 212:779–783
Jaganmohan P, Daas BP, Prasad S (2013) Production of single cell protein (SCP) with Aspergillus terreus using solid state fermentation. Eur J Biol Sci 5:38–43
Jullesson D, David F, Pfleger B, Nielsen J (2015) Impact of synthetic biology and metabolic engineering on industrial production of fine chemicals. Biotechnol Adv 33:1395–1402
Kataoka M, Sasaki M, Hidalgo A-RG, Nakano M, Shimizu S (2001) Glycolic acid production using ethylene glycol-oxidizing microorganisms. Biosci Biotechnol Biochem 65:2265–2270
Kaushik S et al (2018) Impact of the access tunnel engineering on catalysis is strictly ligand-specific. FEBS J 285:1456–1476
Keasling JD (2010) Manufacturing molecules through metabolic engineering. Science 330:1355–1358
Keating GM (2016) Shingles (herpes zoster) vaccine (zostavax®): a review in the prevention of herpes zoster and postherpetic neuralgia. BioDrugs 30:243–254
Kennedy SB et al (2017) Phase 2 placebo-controlled trial of two vaccines to prevent Ebola in Liberia. N Engl J Med 377:1438–1447
Khan AI, Islam MT, Qadri F (2017) Safety of oral cholera vaccines during pregnancy in developing countries. Hum Vaccin Immunother 13:2245–2246
Khetan A, Malmberg LH, Kyung YS, Sherman DH, Hu WS (1999) Precursor and cofactor as a check valve for cephamycin biosynthesis in Streptomyces clavuligerus. Biotechnol Prog 15:1020–1027
Kieliszek M, Misiewicz A (2014) Microbial transglutaminase and its application in the food industry. A review. Folia Microbiol 59:241–250
Kim H, Yoo SJ, Kang HA (2015) Yeast synthetic biology for the production of recombinant therapeutic proteins. FEMS Yeast Res 15:1–16
Korkalainen M et al (2017) Synergistic proinflammatory interactions of microbial toxins and structural components characteristic to moisture-damaged buildings. Indoor Air 27:13–23
Kumar D, Savitri TN, Verma R, Bhalla T (2008) Microbial proteases and application as laundry detergent additive. Res J Microbiol 3:661–672
Kwong KW, Sivakumar T, Wong W (2016) Intein mediated hyper-production of authentic human basic fibroblast growth factor in Escherichia coli. Sci Rep 6:33948
Labrou NE (2010) Random mutagenesis methods for in vitro directed enzyme evolution. Curr Protein Pept Sci 11:91–100
Lacadena J et al (2007) Fungal ribotoxins: molecular dissection of a family of natural killers. FEMS Microbiol Rev 31:212–237
Lautru S, Deeth RJ, Bailey LM, Challis GL (2005) Discovery of a new peptide natural product by Streptomyces coelicolor genome mining. Nat Chem Biol 1:265–269
Lee J-S, Shin K-S, Pan J-G, Kim C-J (2000) Surface-displayed viral antigens on Salmonella carrier vaccine. Nat Biotechnol 18:645
Lee SY, Choi JH, Xu Z (2003) Microbial cell-surface display. Trends Biotechnol 21:45–52
Levin MJ, Buchwald UK, Gardner J, Martin J, Stek JE, Brown E, Popmihajlov Z (2018) Immunogenicity and safety of zoster vaccine live administered with quadrivalent influenza virus vaccine. Vaccine 36:179–185
Lewis K, Epstein S, D’Onofrio A, Ling LL (2010) Uncultured microorganisms as a source of secondary metabolites. J Antibiot 63:468
Li T et al (2012) Efficient, chemoenzymatic process for manufacture of the boceprevir bicyclic [3.1. 0] proline intermediate based on amine oxidase-catalyzed desymmetrization. J Am Chem Soc 134:6467–6472
Li X-F et al (2018) Development of a chimeric Zika vaccine using a licensed live-attenuated flavivirus vaccine as backbone. Nat Commun 9:673
Liew WH, Hassim MH, Ng DK (2014) Review of evolution, technology and sustainability assessments of biofuel production. J Clean Prod 71:11–29
Liljeqvist S, Samuelson P, Hansson M, Nguyen TN, Binz H, Ståhl S (1997) Surface display of the cholera toxin B subunit on Staphylococcus xylosus and Staphylococcus carnosus. Appl Environ Microbiol 63:2481–2488
Lim CG, Fowler ZL, Hueller T, Schaffer S, Koffas MA (2011) High-yield resveratrol production in engineered Escherichia coli. Appl Environ Microbiol 77:3451–3460. https://doi.org/10.1128/AEM.02186-10
Link E et al (1992) Tetanus toxin action: inhibition of neurotransmitter release linked to synaptobrevin proteolysis. Biochem Biophys Res Commun 189:1017–1023
Liu C, Zhao Y, Wang Y (2006) Artemisinin: current state and perspectives for biotechnological production of an antimalarial drug. Appl Microbiol Biotechnol 72:11–20
Liu G, Chater KF, Chandra G, Niu G, Tan H (2013) Molecular regulation of antibiotic biosynthesis in Streptomyces. Microbiol Mol Biol Rev 77:112–143
Luchese RH, Harrigan W (1993) Biosynthesis of aflatoxin—the role of nutritional factors. J Appl Bacteriol 74:5–14
Lutz S (2010) Beyond directed evolution—semi-rational protein engineering and design. Curr Opin Biotechnol 21:734–743
Ma Q et al (2017) Systems metabolic engineering strategies for the production of amino acids. Synth Syst Biotechnol 2:87–96
Mahan KM et al (2018) Production of single cell protein from agro-waste using Rhodococcus opacus. J Ind Microbiol Biotechnol 45(9):795–801
Mane P, Tale V (2015) Overview of microbial therapeutic enzymes. Int J Curr Microbiol Appl Sci 4:17–26
Marinelli F (2009) From microbial products to novel drugs that target a multitude of disease indications. Methods Enzymol 458:29–58
Martin VJ, Pitera DJ, Withers ST, Newman JD, Keasling JD (2003) Engineering a mevalonate pathway in Escherichia coli for production of terpenoids. Nat Biotechnol 21:796
Martínez JL, Liu L, Petranovic D, Nielsen J (2012) Pharmaceutical protein production by yeast: towards production of human blood proteins by microbial fermentation. Curr Opin Biotechnol 23:965–971
Masuyer G, Conrad J, Stenmark P (2017) The structure of the tetanus toxin reveals pH-mediated domain dynamics. EMBO Rep 18:1306–1317
Mazet I, Vey A (1995) Hirsutellin A, a toxic protein produced in vitro by Hirsutella thompsonii. Microbiology 141:1343–1348
McWilliams A (2012) Microbial products: technologies, applications and global markets. BCC Research
Mei Y-Z, Liu R-X, Wang D-P, Wang X, Dai C-C (2015) Biocatalysis and biotransformation of resveratrol in microorganisms. Biotechnol Lett 37:9–18
Milner M (2008) Nattokinase: clinical updates from doctors support its safety and efficacy. FOCUS Allergy Res Group News: Lett
Minami H, Kim J-S, Ikezawa N, Takemura T, Katayama T, Kumagai H, Sato F (2008) Microbial production of plant benzylisoquinoline alkaloids. Proc Natl Acad Sci 105:7393–7398
Mishra B, Reiling S, Zarena D, Wang G (2017) Host defense antimicrobial peptides as antibiotics: design and application strategies. Curr Opin Chem Biol 38:87–96
Morris AP, Estes MK (2001) VIII. Pathological consequences of rotavirus infection and its enterotoxin. Am J Physiol Gastrointest Liver Physiol 281:G303–G310
Moyes DL et al (2016) Candidalysin is a fungal peptide toxin critical for mucosal infection. Nature 532:64
Mrudula S, Murugammal R (2011) Production of cellulase by Aspergillus niger under submerged and solid state fermentation using coir waste as a substrate. Braz J Microbiol 42:1119–1127
Nagasawa T, Nakamura T, Yamada H (1990) Production of acrylic acid and methacrylic acid using Rhodococcus rhodochrous J1 nitrilase. Appl Microbiol Biotechnol 34:322–324
Nakamura J, Hirano S, Ito H, Wachi M (2007) Mutations of the Corynebacterium glutamicum NCgl1221 gene, encoding a mechanosensitive channel homolog, induce L-glutamic acid production. Appl Environ Microbiol 73:4491–4498
Naughton LM, Romano S, O’Gara F, Dobson AD (2017) Identification of secondary metabolite gene clusters in the Pseudovibrio genus reveals encouraging biosynthetic potential toward the production of novel bioactive compounds. Front Microbiol 8:1494
Nayeem M, Chauhan K, Khan S, Rattu G, Dhaka RK, Sidduqui H (2017) Optimization of low-cost substrate for the production of single cell protein using Kluyveromyces marxianus. Pharma Innov J 6:22–25
Nelson DL, Lehninger AL, Cox MM (2008) Lehninger principles of biochemistry. Macmillan
Nevalainen H, Peterson R (2014) Making recombinant proteins in filamentous fungi-are we expecting too much? Front Microbiol 5:75
Newman DJ (2016) Predominately uncultured microbes as sources of bioactive agents. Front Microbiol 7:1832
Newman JD et al (2006) High-level production of amorpha-4, 11-diene in a two-phase partitioning bioreactor of metabolically engineered Escherichia coli. Biotechnol Bioeng 95:684–691
Nielsen J (1998) The role of metabolic engineering in the production of secondary metabolites. Curr Opin Microbiol 1:330–336
Nigam PS (2013) Microbial enzymes with special characteristics for biotechnological applications. Biomol Ther 3:597–611
Nijkamp K, Westerhof RM, Ballerstedt H, De Bont JA, Wery J (2007) Optimization of the solvent-tolerant Pseudomonas putida S12 as host for the production of p-coumarate from glucose. Appl Microbiol Biotechnol 74:617–624
Noda S et al (2011) Cinnamic acid production using Streptomyces lividans expressing phenylalanine ammonia lyase. J Ind Microbiol Biotechnol 38:643–648
Okai N, Takahashi C, Hatada K, Ogino C, Kondo A (2014) Disruption of pknG enhances production of gamma-aminobutyric acid by Corynebacterium glutamicum expressing glutamate decarboxylase. AMB Express 4:20
Olombrada M, Martínez-del-Pozo Á, Medina P, Budia F, Gavilanes JG, García-Ortega L (2014) Fungal ribotoxins: natural protein-based weapons against insects. Toxicon 83:69–74
Olson KC et al (1981) Purified human growth hormone from E. coli is biologically active. Nature 293:408
Olson DM et al (2011) A qualitative assessment of practices associated with shorter door-to-needle time for thrombolytic therapy in acute ischemic stroke. J Neurosci Nurs 43:329–336
Orth JD, Thiele I, Palsson BØ (2010) What is flux balance analysis? Nat Biotechnol 28:245
Ostlie DJ et al (2012) Topical silver sulfadiazine vs collagenase ointment for the treatment of partial thickness burns in children: a prospective randomized trial. J Pediatr Surg 47:1204–1207
Overton TW (2014) Recombinant protein production in bacterial hosts. Drug Discov Today 19:590–601
Paddon CJ, Keasling JD (2014) Semi-synthetic artemisinin: a model for the use of synthetic biology in pharmaceutical development. Nat Rev Microbiol 12:355
Paddon CJ et al (2013) High-level semi-synthetic production of the potent antimalarial artemisinin. Nature 496:528
Pasricha S, Pearson J (2016) Lifting the veil on fungal toxins. Nature Publishing Group
Patel RN (2008) Synthesis of chiral pharmaceutical intermediates by biocatalysis. Coord Chem Rev 252:659–701
Prado-Rubio OA, Jørgensen JB, Jørgensen SB (2010) Systematic model analysis for single cell protein (scp) production in a u-loop reactor. In: Computer aided chemical engineering, vol 28. Elsevier, Amsterdam, pp 319–324
Prokop Z, Gora A, Brezovsky J, Chaloupkova R, Stepankova V, Damborsky J (2012) Engineering of protein tunnels: keyhole-lock-key model for catalysis by the enzymes with buried active sites, vol 3. Wiley-VCH, Weinheim
Quesada-Moraga E, Alain V (2004) Bassiacridin, a protein toxic for locusts secreted by the entomopathogenic fungus Beauveria bassiana. Mycol Res 108:441–452
Rao MB, Varma A, Deshmukh SS (2010) Production of single cell protein, essential amino acids, and xylanase by Penicillium janthinellum. BioResources 5:2470–2477
Raspor P, Goranovič D (2008) Biotechnological applications of acetic acid bacteria. Crit Rev Biotechnol 28:101–124
Rathod PK, McErlean T, Lee P-C (1997) Variations in frequencies of drug resistance in Plasmodium falciparum. Proc Natl Acad Sci 94:9389–9393
Ray G, Noori MT, Ghangrekar M (2017) Novel application of peptaibiotics derived from Trichoderma sp. for methanogenic suppression and enhanced power generation in microbial fuel cells. RSC Adv 7:10707–10717
Reed JL, Senger RS, Antoniewicz MR, Young JD (2011) Computational approaches in metabolic engineering. J Biomed Res 2010
Renge V, Khedkar S, Nandurkar NR (2012) Enzyme synthesis by fermentation method: a review. Sci Rev Chem Comm 2:585e590
Rodríguez-Zavala J, Ortiz-Cruz M, Mendoza-Hernández G, Moreno-Sánchez R (2010) Increased synthesis of α-tocopherol, paramylon and tyrosine by Euglena gracilis under conditions of high biomass production. J Appl Microbiol 109:2160–2172
Rosano GL, Ceccarelli EA (2014) Recombinant protein expression in Escherichia coli: advances and challenges. Front Microbiol 5:172
Rosenberg ZM-M (2006) Current trends of β-galactosidase application in food technology. J Food Nutr Res 45:47–54
Sadia S, Qureshi R, Khalid S, Nayyar BG, Zhang JT (2015) Role of secondary metabolites of wild marigold in suppression of Johnson grass and Sun spurge. Asian Pac J Trop Biomed 5:733–737
Sanchez S, Demain AL (2017) Useful microbial enzymes—an introduction. In: Biotechnology of microbial enzymes. Elsevier, Amsterdam, pp 1–11
Sanchez-Garcia L, Martín L, Mangues R, Ferrer-Miralles N, Vázquez E, Villaverde A (2016) Recombinant pharmaceuticals from microbial cells: a 2015 update. Microb Cell Factories 15:33
Sanders JW, Leenhouts K, Burghoorn J, Brands JR, Venema G, Kok J (1998) A chloride-inducible acid resistance mechanism in Lactococcus lactis and its regulation. Mol Microbiol 27:299–310
Sandström AG, Wikmark Y, Engström K, Nyhlén J, Bäckvall JE (2012) Combinatorial reshaping of the Candida antarctica lipase A substrate pocket for enantioselectivity using an extremely condensed library. Proc Natl Acad Sci 109:78–83
Schmidt-Dannert C (2017) The future of biologically inspired next-generation factories for chemicals. Microb Biotechnol 10:1164–1166
Schmit J, Edson CM, Brody S (1975) Changes in glucosamine and galactosamine levels during conidial germination in Neurospora crassa. J Bacteriol 122:1062–1070
Sette A, Rappuoli R (2010) Reverse vaccinology: developing vaccines in the era of genomics. Immunity 33:530–541
Sharma N (2016) How does recent understanding of molecular mechanisms in botulinum toxin impact therapy? In: Botulinum toxin therapy manual for dystonia and spasticity. InTech open. doi:https://doi.org/10.5772/66696
Sharma A, Chaudhuri TK (2017) Revisiting Escherichia coli as microbial factory for enhanced production of human serum albumin. Microb Cell Factories 16:173
Sharma A, Kumari N, Menghani E (2014) Bioactive secondary metabolites: an overview. Int J Sci Eng Res 5:1395–1407
Sharma S et al (2018) Immunogenicity and safety of the first indigenously developed Indian tetravalent influenza vaccine (split virion) in healthy adults ≥18 years of age: a randomized, multicenter, phase II/III clinical trial. Hum Vaccin Immunother 14(6):1362–1369
Shin JH, Kim HU, Kim DI, Lee SY (2013) Production of bulk chemicals via novel metabolic pathways in microorganisms. Biotechnol Adv 31:925–935
Siegel JB et al (2010) Computational design of an enzyme catalyst for a stereoselective bimolecular Diels-Alder reaction. Science 329:309–313
Singh Saharan B, Grewal A, Kumar P (2014) Biotechnological production of polyhydroxyalkanoates: a review on trends and latest developments. Chin J Biol 2014:802984
Singh HB, Jha A, Keswani C (2016a) Intellectual property issues in biotechnology. CABI, Wallingford/Boston
Singh R, Kumar M, Mittal A, Mehta PK (2016b) Microbial enzymes: industrial progress in 21st century. 3 Biotech 6:174
Stanley M (2007) Prevention strategies against the human papillomavirus: the effectiveness of vaccination. Gynecol Oncol 107:S19–S23
Starcevic A, Zucko J, Simunkovic J, Long PF, Cullum J, Hranueli D (2008) ClustScan: an integrated program package for the semi-automatic annotation of modular biosynthetic gene clusters and in silico prediction of novel chemical structures. Nucleic Acids Res 36:6882–6892
Stewart G, Panchal CJ, Russell I, Sills AM (1983) Biology of ethanol-producing microorganisms. Crit Rev Biotechnol 1:161–188
Suman G, Nupur M, Anuradha S, Pradeep B (2015) Single cell protein production: a review. Int J Curr Microbiol App Sci 4(9): 251–262
Tan JP, Md. Jahim J, Wu TY, Harun S, Kim BH, Mohammad AW (2014) Insight into biomass as a renewable carbon source for the production of succinic acid and the factors affecting the metabolic flux toward higher succinate yield. Ind Eng Chem Res 53:16123–16134
Taylor MJ, Richardson T (1979) Applications of microbial enzymes in food systems and in biotechnology. In: Advances in applied microbiology, vol 25. Elsevier, Burlington, pp 7–35
Terpe K (2006) Overview of bacterial expression systems for heterologous protein production: from molecular and biochemical fundamentals to commercial systems. Appl Microbiol Biotechnol 72:211
Thies S et al (2016) Metagenomic discovery of novel enzymes and biosurfactants in a slaughterhouse biofilm microbial community. Sci Rep 6:27035
Timmis KN, McGenity T, Van Der Meer JR, de Lorenzo V (2010) Handbook of hydrocarbon and lipid microbiology, vol DLII. Springer, Berlin, p 4716
Ueno H (2000) Enzymatic and structural aspects on glutamate decarboxylase. J Mol Catal B Enzym 10:67–79
Ugbogu E, Ugbogu O (2016) A review of microbial protein production: prospects and challenges. Fuw Trends Sci Technol J 1:182–185
Underkofler L, Barton R, Rennert S (1958) Production of microbial enzymes and their applications. Appl Microbiol 6:212
Vaishnav P, Demain AL (2011) Unexpected applications of secondary metabolites. Biotechnol Adv 29:223–229
Vandenbergh PA (1993) Lactic acid bacteria, their metabolic products and interference with microbial growth. FEMS Microbiol Rev 12:221–237
Vandenberghe LP, Soccol CR, Pandey A, Lebeault J-M (1999) Microbial production of citric acid. Braz Arch Biol Technol 42:263–276
Vannelli T, Qi WW, Sweigard J, Gatenby AA, Sariaslani FS (2007) Production of p-hydroxycinnamic acid from glucose in Saccharomyces cerevisiae and Escherichia coli by expression of heterologous genes from plants and fungi. Metab Eng 9:142–151
Vargas-Tah A, Gosset G (2015) Production of cinnamic and p-hydroxycinnamic acids in engineered microbes. Front Bioeng Biotechnol 3:116
Verier A, Chenal A, Babon A, Ménez A, Gillet D (2006) Engineering of bacterial toxins for research and medicine. In: The comprehensive sourcebook of bacterial protein toxins, 3rd edn. Elsevier, Amsterdam/Boston, p 991–1007
Volesky B, Luong JH, Aunstrup K (1984) Microbial enzymes: production, purification, and isolation. Crit Rev Biotechnol 2:119–146
Wang G (2015) Improved methods for classification, prediction, and design of antimicrobial peptides. In: Computational peptidology. Springer, New York/Heidelberg, pp 43–66
Wang G, Huang M, Nielsen J (2017) Exploring the potential of Saccharomyces cerevisiae for biopharmaceutical protein production. Curr Opin Biotechnol 48:77–84
Weber T, Rausch C, Lopez P, Hoof I, Gaykova V, Huson D, Wohlleben W (2009) CLUSEAN: a computer-based framework for the automated analysis of bacterial secondary metabolite biosynthetic gene clusters. J Biotechnol 140:13–17
Wee Y-J, Kim J-N, Ryu H-W (2006) Biotechnological production of lactic acid and its recent applications. Food Technol Biotechnol 44:163–172
Williams DH, Stone MJ, Hauck PR, Rahman SK (1989) Why are secondary metabolites (natural products) biosynthesized? J Nat Prod 52:1189–1208
Williamson NR, Fineran PC, Leeper FJ, Salmond GP (2006) The biosynthesis and regulation of bacterial prodiginines. Nat Rev Microbiol 4:887
de Wit PJ (2013) Microbial toxins in the green world. FEMS Microbiol Rev 37:1–2
Wu F, Cao P, Song G, Chen W, Wang Q (2018) Expanding the repertoire of aromatic chemicals by microbial production. J Chem Technol Biotechnol 93:2804–2816
Xing B, Rao J, Liu R (2008) Novel beta-lactam antibiotics derivatives: their new applications as gene reporters, antitumor prodrugs and enzyme inhibitors. Mini Rev Med Chem 8:455–471
Xu Q, Tao W-Y, Huang H, Li S (2016) Highly efficient synthesis of ethyl (S)-4-chloro-3-hydroxybutanoate by a novel carbonyl reductase from Yarrowia lipolytica and using mannitol or sorbitol as cosubstrate. Biochem Eng J 106:61–67
Yang X, Yousef AE (2018) Antimicrobial peptides produced by Brevibacillus spp.: structure, classification and bioactivity: a mini review. World J Microbiol Biotechnol 34:57
Yoo YJ, Feng Y, Kim Y-H, Yagonia CFJ (2017) Fundamentals of enzyme engineering. Springer, p X, 209
Zahrl RJ, Peña DA, Mattanovich D, Gasser B (2017) Systems biotechnology for protein production in Pichia pastoris. FEMS Yeast Res 17:fox068
Zhao S et al (2013) Discovery of new enzymes and metabolic pathways by using structure and genome context. Nature 502:698
Zheng P, Dong J-J, Sun Z-H, Ni Y, Fang L (2009) Fermentative production of succinic acid from straw hydrolysate by Actinobacillus succinogenes. Bioresour Technol 100:2425–2429
Zhu X, Siegert M, Yates MD, Logan BE (2015) Alamethicin suppresses methanogenesis and promotes acetogenesis in bioelectrochemical systems. Appl Environ Microbiol 81:3863–3868
Zorko M, Jerala R (2010) Production of recombinant antimicrobial peptides in bacteria. In: Antimicrobial peptides. Springer, pp 61–76
Zubieta MP, Contesini FJ, Rubio MV, Gonçalves AESS, Gerhardt JA, Prade RA, Damasio ARL (2018) Protein profile in Aspergillus nidulans recombinant strains overproducing heterologous enzymes. Microb Biotechnol 11:346–358
Acknowledgement
SK is thankful to the Department of Biotechnology (DBT) (BT/P19588/BIC/101/425/2016) for their financial assistance and National Institute of Pharmaceutical Education and Research (NIPER), Guwahati, for providing the necessary support.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Johnson, A., Deshmukh, P., Kaushik, S., Sharma, V. (2019). Microbial Bio-production of Proteins and Valuable Metabolites. In: Singh, D., Gupta, V., Prabha, R. (eds) Microbial Interventions in Agriculture and Environment. Springer, Singapore. https://doi.org/10.1007/978-981-13-8391-5_15
Download citation
DOI: https://doi.org/10.1007/978-981-13-8391-5_15
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-8390-8
Online ISBN: 978-981-13-8391-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)